{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:55:15Z","timestamp":1790013315086,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Foamix Pharmaceuticals, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaad.2020.01.043","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:28:32Z","timestamp":1580228912000},"page":"1166-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials"],"prefix":"10.1016","volume":"82","author":[{"given":"Linda Stein","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Q.","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Kircik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Nahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.01.043_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cgh.2015.09.013","article-title":"Rosacea, use of tetracycline, and risk of incident inflammatory bowel disease in women","volume":"14","author":"Li","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2020.01.043_bib2","first-page":"654","article-title":"Cost-effectiveness of ivermectin 1% cream in adults with papulopustular rosacea in the United States","volume":"22","author":"Taieb","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jaad.2020.01.043_bib3","doi-asserted-by":"crossref","first-page":"e1361574","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2020.01.043_bib4","first-page":"187","article-title":"Rosacea: diagnosis and treatment","volume":"92","author":"Oge","year":"2015","journal-title":"Am Fam Physician"},{"issue":"Suppl 6","key":"10.1016\/j.jaad.2020.01.043_bib5","first-page":"17","article-title":"Rosacea management: update on general measures and topical treatment options","volume":"14","author":"Schaller","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2020.01.043_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40257-017-0339-0","article-title":"A phase II, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular rosacea","volume":"19","author":"Mrowietz","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.01.043_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jcma.2018.01.008","article-title":"Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs","volume":"81","author":"Yokota","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jaad.2020.01.043_bib8","series-title":"Handbook of Formulating Dermal Applications: A Definitive Practical Guide","first-page":"233","article-title":"Foam: a unique delivery vehicle for topically applied formulations","author":"Tamarkin","year":"2016"},{"key":"10.1016\/j.jaad.2020.01.043_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/ijd.12339","article-title":"The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial","volume":"53","author":"Evangelista","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.01.043_bib10","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.3390\/ijms19010070","article-title":"Anti-inflammatory and skin barrier repair effects of topical application of some plant oils","volume":"19","author":"Lin","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2020.01.043_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jtcme.2017.06.012","article-title":"In\u00a0vitro anti-inflammatory and skin protective properties of virgin coconut oil","volume":"9","author":"Varma","year":"2019","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.jaad.2020.01.043_bib12","first-page":"18","article-title":"Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies","volume":"93","author":"Del Rosso","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.01.043_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220301274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220301274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:42Z","timestamp":1759272762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220301274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0190962220301274"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.01.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}